Limited efficacy of pentoxifylline as anti-inflammatory agent in experimental pneumococcal meningitis
1Department of Neurology, University of Göttingen, Germany.
Abstract:
Dexamethasone appears to show some adverse side-effects as adjunctive anti-inflammatory agent in bacterial meningitis. For this reason, we tested the anti-inflammatory and neuroprotective effect of pentoxifylline administered 15 min before starting antibiotic treatment with ceftriaxone (n = 10) versus antibiotic therapy alone (n = 9) in the rabbit model of pneumococcal meningitis. Pentoxifylline lowered the medians of leucocyte density, tumour necrosis factor-alpha (TNF-alpha) and lactate in the cerebrospinal fluid (CSF), but only leucocyte migration into the subarachnoid space was significantly inhibited 8 h after initiation of therapy (P = 0.01). CSF protein, brain water content, and the entry of ceftriaxone into CSF were not influenced by pentoxifylline. The density of neuronal apoptoses in the dentate gyrus was slightly lower in animals receiving pentoxifylline than in those treated with ceftriaxone only. The median concentration of neuron-specific enolase in CSF was lower in the pentoxifylline-treated group, but the difference was not significant. In conclusion, pentoxifylline showed some anti-inflammatory activity in pneumococcal meningitis, but the substance failed significantly to reduce neuronal damage.
Insights
Pentoxifylline demonstrated anti-inflammatory effects in rabbit pneumococcal meningitis by reducing inflammatory markers. However, it did not significantly prevent neuronal damage, unlike dexamethasone which has adverse side effects.
Area of Science:
- Neuroscience
- Pharmacology
- Infectious Diseases
Background:
- Dexamethasone, an anti-inflammatory agent, presents adverse side effects in bacterial meningitis treatment.
- Exploring alternative anti-inflammatory and neuroprotective agents is crucial for managing meningitis.
Purpose of the Study:
- To evaluate the anti-inflammatory and neuroprotective effects of pentoxifylline in a rabbit model of pneumococcal meningitis.
- To compare pentoxifylline's efficacy when administered before ceftriaxone antibiotic treatment versus antibiotic therapy alone.
Main Methods:
- Rabbits with pneumococcal meningitis were treated with pentoxifylline and ceftriaxone (n=10) or ceftriaxone alone (n=9).
- Cerebrospinal fluid (CSF) analysis included leucocyte density, tumor necrosis factor-alpha (TNF-alpha), lactate, and protein.
- Neuronal apoptosis and brain water content were assessed; ceftriaxone entry into CSF was measured.
Main Results:
- Pentoxifylline significantly inhibited leucocyte migration into the subarachnoid space (P=0.01).
- It lowered CSF levels of leucocyte density, TNF-alpha, and lactate.
- No significant influence on CSF protein, brain water content, or ceftriaxone entry was observed. Neuronal apoptosis showed a slight, non-significant reduction.
Conclusions:
- Pentoxifylline exhibits partial anti-inflammatory activity in pneumococcal meningitis.
- The drug did not significantly reduce neuronal damage or apoptosis in this model.
- Further research is needed to explore pentoxifylline's therapeutic potential in meningitis.
More Related Videos
08:47Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
06:57Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
